Clinical Trials Browser

Phase 1 × Leukemia, Hairy Cell × immunotoxin HA22 × Clear all

NCT03805932 2025-07-24

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Phase 1 Active not recruiting

18 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Hairy Cell

NCT00586924 2019-04-02

A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia

Phase 1 Completed

49 enrolled 40 charts

Other hematologic neoplasm

Leukemia, Hairy Cell

NCT00462189 2007-04-18

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell, Recurrence